PROJECT OVERVIEW
The study "Phase III clinical trial, randomized, partially double-blind, controlled to compare the immunogenicity and safety of the liquid form of Rotavin vaccine with the currently licensed frozen form (Rotavin-M1) in healthy children in Vietnam" was conducted starting in 2020 at the Vaccine and Medical Biological Products Research and Production Center (POLYVAC).
Research Details
- TOPIC NAME Phase III clinical trial comparing immunogenicity and safety of liquid Rotavin vaccine vs. licensed frozen Rotavin-M1 in healthy Vietnamese children.
- Name of the principal PATH Organization and POLYVAC
- Classification Joint projects with domestic and international organizations
- Execution time 2024
Project/Topic Results
Test results
Rotavin-M1 vaccine can be stored at 2-8°C, which is convenient for transportation and storage
Related Studies
